August 20, 2020
The use of cognitive-behavioral therapy interventions, such as Big Health’s Sleepio program, has been found to improve both sleep and mental health in individuals with insomnia and clinically significant depressive symptoms, according to new research published in the Journal of Sleep Research.
Sleepio is a digital sleep-improvement program that offers personalized treatment base on a user’s...
August 18, 2020
Sweden-based digital therapeutics respiratory company, NuvoAir, has been certified as a Class Im medical device.
The NuvoAir Home platform includes Air Next, a certified bluetooth spirometer, a connected patient app and a healthcare portal.
WHY IT MATTERS
Patients can use the platform to self-monitor their respiratory health and share clinically relevant data with their care teams, who can view...
July 29, 2020
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers.
The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...
July 22, 2020
Editor's note: This story has been updated with the timing and size of the pilot.
Scottsdale, Arizona-based Magellan Health announced today that it has launched a pilot of Boston Children's Hospital spin-out Neuromotion Labs' Mightier, a biofeedback video game platform designed to help children regulate their emotions.
Since June 22, the managed care company has begun supplying members with...
July 21, 2020
New research demonstrated that patients using a digital treatment for nonspecific low back pain report significantly stronger pain reduction compared to their peers receiving the standard of care.
The cluster-randomized study, published in the Journal of Pain Research, compared patients using traditional treatment methods to those using a digital program called Rise-uP, which combined electronic...
July 20, 2020
Sustained engagement is a key metric when determining whether a digital health-based intervention is finding its mark, but the industry has been anything but uniform in determining objective measures of user behavior and their relationship to clinical outcomes.
A study published Friday in JAMA Network Open takes another approach and employs machine learning techniques to better describe...
July 14, 2020
A study found that using the digital therapeutic app MyCognition can ease perception of cognitive decline in breast cancer patients.
Around 75% of breast cancer patients report experiencing cognitive decline known as ‘chemo brain’ during or after treatment, according to research.
In a clinical trial at the University of Antwerp, between 2016 and 2020, experts investigated whether the app...
July 13, 2020
Swedish pharma company Orexo is jumping into the American digital-therapeutics game with the announcement of two new products, deprexis for treating depression symptoms and vorvida, a treatment for problematic alcohol use.
The new treatments are coming to the US market thanks to relaxed FDA regulations surrounding digital health products for psychiatric disorders, which was enacted as a result...
July 9, 2020
AliveCor released today KardiaCare, a digital subscription service for managing heart health at home.
The service offers a suite of features that helps users interpret their heart data, monitor risk factors, identify symptom triggers and measure the impact of lifestyle changes. It will expand upon the features already provided with the company’s other ECG products, KardiaMobile and KardiaMobile...
July 8, 2020
Barcelona, Spain-based digital therapeutic company Braingaze announced that it is partnering with China’s insurance giant Ping An Group and eye-tracking innovator 7invensun to deliver convenient and accurate diagnostic solutions to kids in China who are suffering from ADHD disorders.
As part of a broader collaboration with Ping An Group, the health services giant in China, Braingaze set out to...